- Home
- MNPR vs CTRN Comparison
MNPR vs CTRN Comparison
Compare MNPR & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CTRN
- Stock Information
- Founded
- MNPR 2014
- CTRN 1946
- Country
- MNPR United States
- CTRN United States
- Employees
- MNPR N/A
- CTRN N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CTRN Clothing/Shoe/Accessory Stores
- Sector
- MNPR Health Care
- CTRN Consumer Discretionary
- Exchange
- MNPR Nasdaq
- CTRN Nasdaq
- Market Cap
- MNPR 248.8M
- CTRN 280.0M
- IPO Year
- MNPR 2019
- CTRN 2005
- Fundamental
- Price
- MNPR $35.71
- CTRN $31.97
- Analyst Decision
- MNPR Strong Buy
- CTRN Buy
- Analyst Count
- MNPR 7
- CTRN 2
- Target Price
- MNPR $62.00
- CTRN $24.50
- AVG Volume (30 Days)
- MNPR 20.7K
- CTRN 50.7K
- Earning Date
- MNPR 08-12-2025
- CTRN 08-26-2025
- Dividend Yield
- MNPR N/A
- CTRN N/A
- EPS Growth
- MNPR N/A
- CTRN N/A
- EPS
- MNPR N/A
- CTRN N/A
- Revenue
- MNPR N/A
- CTRN $768,518,000.00
- Revenue This Year
- MNPR N/A
- CTRN $6.80
- Revenue Next Year
- MNPR N/A
- CTRN $4.61
- P/E Ratio
- MNPR N/A
- CTRN N/A
- Revenue Growth
- MNPR N/A
- CTRN 1.85
- 52 Week Low
- MNPR $2.15
- CTRN $13.66
- 52 Week High
- MNPR $54.30
- CTRN $34.63
- Technical
- Relative Strength Index (RSI)
- MNPR 43.81
- CTRN 55.99
- Support Level
- MNPR $30.51
- CTRN $30.06
- Resistance Level
- MNPR $36.51
- CTRN $33.49
- Average True Range (ATR)
- MNPR 3.33
- CTRN 1.16
- MACD
- MNPR -0.95
- CTRN 0.25
- Stochastic Oscillator
- MNPR 37.55
- CTRN 69.90
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.